Ligand validation:7ZU2

IMD: IMIDAZOLE

IMD is a Ligand Of Interest in 7ZU2 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7ZU2_IMD_A_1002	45%	75%	0.127	0.856	0.28	0.68	-	-	0	0	100%	0.8
7ZU2_IMD_A_1003	33%	75%	0.144	0.823	0.39	0.58	-	-	0	0	100%	1
7ZTZ_IMD_A_1002	54%	83%	0.141	0.904	0.22	0.55	-	-	0	0	100%	1
7ZU1_IMD_A_1005	16%	72%	0.152	0.717	0.31	0.75	-	-	0	0	100%	1
7ZTX_IMD_A_1004	10%	74%	0.201	0.708	0.27	0.74	-	-	0	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
6THT_IMD_A_301	100%	89%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
5OKB_IMD_B_502	100%	75%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	100%	52%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.